GeoVax Other Stockholder Equity from 2010 to 2025

GOVXW Stock  USD 0.05  0.02  30.14%   
GeoVax Labs Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2025. During the period from 2010 to 2025, GeoVax Labs Other Stockholder Equity regression line of quarterly data had mean square error of 1589782334628956.2 T and geometric mean of  264,885,061. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2000-03-31
Previous Quarter
113 M
Current Value
129.6 M
Quarterly Volatility
29.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.4 K, Total Revenue of 0.0 or Other Operating Expenses of 32.3 M, as well as many indicators such as Price To Sales Ratio of 205, Dividend Yield of 0.0 or PTB Ratio of 0.0. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.
  
Check out the analysis of GeoVax Labs Correlation against competitors.
For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

Latest GeoVax Labs' Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of GeoVax Labs over the last few years. It is GeoVax Labs' Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeoVax Labs' overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

GeoVax Other Stockholder Equity Regression Statistics

Arithmetic MeanHuge
Geometric Mean264,885,061
Coefficient Of Variation273.34
Mean DeviationHuge
Median37,927,898
Standard DeviationHuge
Sample Variance2215734699881458.2T
Range141.1T
R-Value0.57
Mean Square Error1589782334628956.2T
R-Squared0.33
Significance0.02
Slope5,682,550,124,883
Total Sum of Squares33236020498221876T

GeoVax Other Stockholder Equity History

2025141.1 T
2024134.4 T
2023110.1 M
2022105 M
202168.7 M
202055.3 M
201939.3 M

About GeoVax Labs Financial Statements

GeoVax Labs investors use historical fundamental indicators, such as GeoVax Labs' Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity134.4 T141.1 T

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.